ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 146 filers reported holding ALLAKOS INC in Q4 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1 | 0.0% | 343 | 0.0% | 0.00% | – |
Q2 2023 | $1 | -50.0% | 343 | 0.0% | 0.00% | – |
Q1 2023 | $2 | -33.3% | 343 | 0.0% | 0.00% | – |
Q4 2022 | $3 | -99.7% | 343 | +117.1% | 0.00% | – |
Q3 2022 | $1,000 | – | 158 | 0.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 158 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | -50.0% | 158 | 0.0% | 0.00% | – |
Q4 2021 | $2,000 | -90.0% | 158 | -14.6% | 0.00% | – |
Q3 2021 | $20,000 | +122.2% | 185 | +77.9% | 0.00% | – |
Q2 2021 | $9,000 | -25.0% | 104 | 0.0% | 0.00% | – |
Q1 2021 | $12,000 | -14.3% | 104 | +5.1% | 0.00% | – |
Q4 2020 | $14,000 | -36.4% | 99 | -64.0% | 0.00% | – |
Q3 2020 | $22,000 | +83.3% | 275 | 0.0% | 0.00% | – |
Q2 2020 | $12,000 | 0.0% | 275 | 0.0% | 0.00% | – |
Q1 2020 | $12,000 | -53.8% | 275 | 0.0% | 0.00% | – |
Q4 2019 | $26,000 | +8.3% | 275 | -10.7% | 0.00% | – |
Q3 2019 | $24,000 | +100.0% | 308 | +14.9% | 0.00% | – |
Q2 2019 | $12,000 | +9.1% | 268 | 0.0% | 0.00% | – |
Q1 2019 | $11,000 | -31.2% | 268 | -10.7% | 0.00% | – |
Q4 2018 | $16,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |